山东药械监管改革：质量与效率并行，安全与创新共赢

Core Viewpoint - The Shandong Provincial Government has introduced a set of implementation opinions aimed at enhancing the regulatory framework for pharmaceuticals and medical devices, focusing on high-quality development while ensuring safety, effectiveness, and quality control [1][3]. Group 1: Regulatory Efficiency and Transparency - The Shandong Provincial Drug Administration aims to improve the efficiency of review and approval processes while maintaining strict adherence to safety and quality standards [3]. - A series of institutional and mechanistic arrangements will be implemented to achieve a dynamic balance between efficiency and quality control [3]. - The administration will publicly disclose review and approval standards, procedures, timelines, and common questions to enhance transparency and allow companies to prepare adequately [3]. Group 2: Differentiated Review Mechanism - A scientific, tiered review mechanism will be established, providing dedicated support for key pharmaceutical and medical device products with significant clinical value and technological innovation [4]. - For conventional and mature projects, standardized review processes will be optimized to improve efficiency through information technology and templated approaches [4]. - This differentiated model aims to allocate regulatory resources effectively, supporting innovative products while ensuring rigorous standards for routine reviews [4]. Group 3: Professional Capacity Building - The quality of review and approval work is heavily dependent on the professional capabilities of reviewers and inspectors [4]. - Continuous professional development for review personnel will be emphasized through regular training, collaboration with national agencies, and participation in complex case discussions [4]. - The establishment of a provincial expert advisory committee will facilitate input from academia and industry on significant technical issues, ensuring that review conclusions are scientifically sound and robust [4].